Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trex Wind-Down Inc TMBRQ

Healthcare
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.


GREY:TMBRQ - Post by User

Trex Wind-Down Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(20)
•••
Post by ok2buyon May 26, 2021 8:55pm
110 Views
Post# 33273197

News

NewsAfter hours news, company to approach FDA about ending Phase 2a/b trial based on favourable results in enrolled patients.  Looking to move to a Phase III study to further address unmet needs with ichthyosis using drug candidate TMB-001.  This one could move up tomorrow based on  today's news and quickly in the short to mid term to $3.  Best of luck to the longs./ok2
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities